Delivery Order SPE2DB20D2014-SPE2DB25FD09P
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Gentamicin 800 mg/20 mL vials totaling $1,791.07. This is a firm fixed-price delivery order under a non-competitive award with an ultimate completion date of September 18, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued as a child contract...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on June 26, 2025, for the supply of Gentamicin 800 mg/20 mL vials with a contract value of $1,987.23 and an ultimate completion date of June 27, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery supporting federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,704.79 to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Gentamicin 800 mg/20 mL vials. This firm fixed-price delivery order, with an ultimate completion date of June 2, 2025, represents a competitively awarded, non-set-aside procurement action. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Gentamicin 800 mg/20 mL vials. This firm fixed-price delivery order, valued at $8,611.33, is non-competitive and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running through December 2026. The product will be delivered to...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $4,414.01 by the Defense Logistics Agency's Medical Supply Chain for the supply of Gentamicin 800 mg/20 mL vials. The contract, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Gentamicin 800 mg/20 mL vials. This firm fixed-price delivery order, valued at $2,292.52, represents a non-competitive award under an existing contract vehicle and is scheduled for completion by July 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. Gentamicin is a critical antibiotic used in military...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for GENTAMICIN 800 MG/20 ML VIAL 20ML, a pharmaceutical product, with a completion date of February 16, 2024 and a potential value of $3,436.19. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, through its...
- This is a $1,392.65 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4566811385 - GENTAMICIN 800 MG/20 ML VIAL 20ML, with a period of performance ending on December 31, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a $2,741.83 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 800 mg/20 ml vials of the antibiotic Gentamicin, with a performance period through May 12, 2023. This award is a task order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,699.50 by the Defense Logistics Agency's Medical Supply Chain on September 11, 2025. This firm fixed-price delivery order, with a completion date of September 12, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD09PDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 24, 2025, for the supply of Gentamicin 800 mg/20 mL vials with a ceiling value of $4,994.74. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 25, 2025. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under the company's broader federal pharmaceutical supply portfolio with the Defense Logistics Agency. This award is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to deliver a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to fulfill federal medical procurement requirements through open competition across multiple therapeutic domains including antibiotics, pain management pharmaceuticals, and specialized medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 9/24/25 |